OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.750
+0.200 (7.84%)
Nov 20, 2024, 4:00 PM EST - Market closed
OncoCyte Employees
As of December 31, 2023, OncoCyte had 46 total employees, including 43 full-time and 3 part-time employees. The number of employees decreased by 30 or -39.47% compared to the previous year.
Employees
46
Change (1Y)
-30
Growth (1Y)
-39.47%
Revenue / Employee
$15,413
Profits / Employee
-$948,043
Market Cap
46.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Fortress Biotech | 186 |
Xilio Therapeutics | 73 |
Actinium Pharmaceuticals | 49 |
HCW Biologics | 45 |
Gain Therapeutics | 32 |
SCYNEXIS | 29 |
Reviva Pharmaceuticals Holdings | 15 |
CalciMedica | 12 |
OCX News
- 8 days ago - OncoCyte Corporation (OCX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12 - GlobeNewsWire
- 5 weeks ago - Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles - GlobeNewsWire
- 3 months ago - OncoCyte Corporation (OCX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move - GlobeNewsWire
- 6 months ago - Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine - GlobeNewsWire
- 6 months ago - OncoCyte Corporation (OCX) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Oncocyte Reports First Quarter 2024 Financial Results - GlobeNewsWire